Prescription pricing -- CanadaSee also what's at your library, or elsewhere.
Broader terms: |
Filed under: Prescription pricing -- Canada- Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers (U.S. G.P.O. :, 2003), by Science United States. Congress. Senate. Committee on Commerce (page images at HathiTrust)
- Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005. (U.S. G.P.O. :, 2005), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Prescription drugs : companies typically charge more in the United States than in Canada : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives (The Office ;, 1992), by United States General Accounting Office and United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Items below (if any) are from related and broader terms.
Filed under: Prescription pricing
Filed under: Prescription pricing -- Arkansas- Health care reform : the time has come : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : long-term care and prescription drug costs, Fort Smith, AR, February 10, 1992; skyrocketing health care costs and the impact on individuals and businesses, Jonesboro, AR, February 11, 1992; answers to the health care dilemma, El Dorado, AR, February 12, 1992. (U.S. G.P.O. :, 1992), by United States Senate Special Committee on Aging (page images at HathiTrust)
Filed under: Prescription pricing -- Europe
Filed under: Prescription pricing -- Georgia- The effects of escalating drug costs on the elderly : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : morning session, Macon, GA, April 22, 1992; afternoon session, Atlanta, GA, April 22, 1992. (U.S. G.P.O. :, 1992), by United States Senate Special Committee on Aging (page images at HathiTrust)
Filed under: Prescription pricing -- Great Britain
Filed under: Prescription pricing -- Indiana
Filed under: Prescription pricing -- Maine
Filed under: Prescription pricing -- Missouri
Filed under: Prescription pricing -- Northwest, Pacific
Filed under: Prescription pricing -- OregonFiled under: Prescription pricing -- United States- Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
- Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)
- Price Comparisons for Pharmaceuticals: A Review of U.S. and Cross-National Studies (Washington: AEI Press, 1999), by Patricia Munch Danzon (PDF with commentary at AEI)
- Prescription drug price disclosures : staff report to the Federal Trade Commission. (U.S. Govt. Print. Off., 1975), by United States. Federal Trade Commission. Bureau of Consumer Protection and United States Federal Trade Commission (page images at HathiTrust)
- High drug costs for the elderly the need for relief : hearing before the Subcommittee on Human Services of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, second session, September 10, 1984, Bronx, NY. (U.S. G.P.O., 1984), by United States. Congress. House. Select Committee on Aging. Subcommittee on Human Services (page images at HathiTrust)
- Prescription drug price increases hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985. (U.S. G.P.O., 1986), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
- High drug costs and older Americans a prescription for the future : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, Ninety-ninth Congress, second session, October 8, 1986. (U.S. GPO., 1987), by United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)
- Prescription drug costs the growing burden for older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundredth Congress, first session, Little Rock, AR, August 27, 1987. (U.S. G.P.O., 1988), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Skyrocketing prescription drug prices : hearings before the Special Committee on Aging, United States Senate, One Hundred First Congress, first session, Washington, DC ... July 18, 1989 ... November 16, 1989. (U.S. G.P.O. :, 1990), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Medicaid rebate on prescription drugs affects pricing (Congressional Budget Office, 1996), by United States Congressional Budget Office (page images at HathiTrust)
- Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996. (U.S. G.P.O. :, 1996), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
- Medicare prescription drug benefits : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, first session, June 11, 1991. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)
- Prescription drugs and the elderly : the high cost of growing old : hearing before the Special Committee on Aging, United States Senate, One Hundredth Congress, first session, Washington, DC, July 20, 1987. (U.S. G.P.O. :, 1987), by United States Senate Special Committee on Aging (page images at HathiTrust)
- The high cost of prescription drugs : hearing before the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, May 18, 1990, Baltimore, MD. (U.S. G.P.O. :, 1990), by United States. Congress. House. Select Committee on Aging (page images at HathiTrust)
- Implications for beneficiaries of Medicare HMO use of formularies (The Office, 1999), by United States General Accounting Office and Medicare+Choice Program (U.S.) (page images at HathiTrust)
- Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994. (U.S. G.P.O. :, 1995), by United States Senate Committee on Governmental Affairs (page images at HathiTrust)
- International prescription drug prices : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, first session, February 22, 1993. (U.S. G.P.O. :, 1993), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
- Programs to control prescription drug costs under Medicaid and Medicare could be strengthened : report (U.S. General Accounting Office, 1980), by United States General Accounting Office (page images at HathiTrust)
- The effects of escalating drug costs on the elderly : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : morning session, Macon, GA, April 22, 1992; afternoon session, Atlanta, GA, April 22, 1992. (U.S. G.P.O. :, 1992), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Implications for retail pharmacies (The Office ;, 1996), by Sarah F. Jaggar, United States House Committee on Commerce, Subcommittee on Oversight and Investigations, and United States General Accounting Office (page images at HathiTrust)
- Companies typically charge more in the United States than in the United Kingdom (The Office ;, 1994), by United States General Accounting Office and United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
- Medicaid : changes in drug prices paid by VA and DOD since enactment of rebate provisions (The Office, 1991), by United States General Accounting Office (page images at HathiTrust)
- Outpatient prescription drugs : data collection and editing in the 1996 Medical Expenditure Panel Survey (HC-010A). (U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2001), by United States. Agency for Healthcare Research and Quality (page images at HathiTrust)
- Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002. (U.S. G.P.O. :, 2003), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)
- Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers (U.S. G.P.O. :, 2003), by Science United States. Congress. Senate. Committee on Commerce (page images at HathiTrust)
- Issues in designing a prescription drug benefit for Medicare. (Congress of the United States, Congressional Budget Office, 2002), by Christian Spoor, Joseph Antos, and United States Congressional Budget Office (page images at HathiTrust)
- Direct to consumer advertising (DTC) : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, July 24, 2001. (U.S. G.P.O. :, 2004), by Science United States. Congress. Senate. Committee on Commerce (page images at HathiTrust)
- The new Medicare drug discount card : an advance prognosis : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, second session, Washington, DC, March 9, 2004. (U.S. G.P.O. :, 2004), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Medicare discount drug card : measuring the savings : forum before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, second session, Washington, DC, September 23, 2004. (U.S. G.P.O. :, 2005), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Medicare drug card : delivering savings for participating beneficiaries : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, June 8, 2004. (U.S. G.P.O. :, 2005), by United States. Congress. Senate. Committee on Finance (page images at HathiTrust)
- Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005. (U.S. G.P.O. :, 2005), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004. (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
- Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005. (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
- Monitoring Centers for Medicare & Medicaid Services' vital signs (U.S. G.P.O. :, 2006), by the Federal Workforce United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Subcommittee on Oversight of Government Management (page images at HathiTrust)
- Medicare reimbursements of physician administered drugs (U.S. G.P.O. :, 2006), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)
- Exploring the relationship between doctors and the drug industry (U.S. G.P.O. :, 2008), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Prescription drug pricing and negotiation : overview and economic perspectives for the Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, January 11, 2007. (U.S. G.P.O. :, 2007), by United States. Congress. Senate. Committee on Finance (page images at HathiTrust)
- Small market drugs, big price tags : are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008. (U.S. G.P.O. :, 2009), by United States. Congress. Joint Economic Committee (page images at HathiTrust)
- Outpatient prescription drug expenses, 1999 (Rockville, Md. : Agency for Healthcare Research and Quality, 2003., 2003), by Marie Stagnitti, John F. Moeller, G. Edward Miller, and United States. Agency for Healthcare Research and Quality (page images at HathiTrust)
- Prescription drugs : companies typically charge more in the United States than in Canada : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives (The Office ;, 1992), by United States General Accounting Office and United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
- Sales, promotion, and product differentiation in two prescription drug markets (Federal Trade Commission, Bureau of Economics :, 1977), by Ronald S. Bond, David F. Lean, and United States. Federal Trade Commission. Bureau of Economics (page images at HathiTrust)
- Direct to consumer advertising (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
- Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate. (U.S. G.P.O. :, 1989), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Skyrocketing prescription drug prices : turning a bad deal into a fair deal : a majority staff report of the Special Committee on Aging, United States Senate. (Washington : U.S. G.P.O., 1990., 1990), by United States Senate Special Committee on Aging (page images at HathiTrust)
- A Status report, accessibilty and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate. (U.S. G.P.O. :, 1992), by United States Senate Special Committee on Aging (page images at HathiTrust)
- A Status report, accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate. (U.S. G.P.O. :, 1992), by United States Senate Special Committee on Aging (page images at HathiTrust)
- The Drug manufacturing industry : a prescription for profits : staff report of the Special Committee on Aging, United States Senate. (U.S. G.P.O. :, 1991), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Prescription for good health : keeping pharmaceutical prices under control : a briefing (U.S. G.P.O. :, 1992), by United States. Congress. House. Select Committee on Aging. Subcommittee on Human Services (page images at HathiTrust)
- Prescription drug costs : a bitter pill to swallow : joint hearing before the Subcommittee on Housing and Consumer Interests and the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, September 28, 1992, Logansport, IN. (U.S. G.P.O. :, 1993), by United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests and United States. Congress. House. Select Committee on Aging (page images at HathiTrust)
- Prescription drugs : is there a cure for the costs? : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, January 16, 1992, Vancouver, WA. (U.S. G.P.O. :, 1993), by United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)
- Prescription drug costs : the growing burden for older Americans : hearing before the Special Committee on Aging, United States Senate, One Hundredth Congress, first session, Little Rock, AR, August 27, 1987. (U.S. G.P.O. :, 1988), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985. (U.S. G.P.O., 1986), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
- Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007. (U.S. G.P.O. :, 2007), by United States. Congress. Senate. Committee on Finance (page images at HathiTrust)
- Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Sixth Congress, first session, June 23, 1999. (U.S. G.P.O. :, 1999), by United States. Congress. Senate. Committee on Finance (page images at HathiTrust)
- Impact of drug switching on older Americans (U.S. G.P.O. :, 2000), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Coverage of outpatient prescription drugs under Medicare part B : hearings before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundredth Congress, first session, April 23 and June 2, 1987. (U.S. G.P.O. :, 1988), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)
- The Medicare drug benefit : are private insurers getting good discounts for the taxpayer? : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, July 24, 2008. (U.S. G.P.O. :, 2010), by United States House Committee on Oversight and Government Reform (page images at HathiTrust)
- Official index overstates producer price inflation (The Office ;, 1995), by United States General Accounting Office and United States Senate Special Committee on Aging (page images at HathiTrust)
- Reimbursement and access to prescription drugs under Medicare part B : hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002. (U.S. G.P.O. :, 2002), by United States. Congress. Senate. Committee on Finance. Subcommittee on Health Care (page images at HathiTrust)
- High drug costs and older Americans : a prescription for the future : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, Ninety-ninth Congress, second session, October 8, 1986. (U.S. GPO. :, 1987), by United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)
- Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000. (U.S. G.P.O. :, 2000), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
- Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000. (U.S. G.P.O. :, 2000), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
- Prescription drug labeling and price advertising : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 882, H.R. 884, and all identical bills ... . (U.S. Govt. Print. Off., 1977), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance (page images at HathiTrust)
- Direct to consumer advertising of prescription drugs (U.S. G.P.O. :, 2003), by United States Senate Special Committee on Aging (page images at HathiTrust)
- Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002. (U.S. G.P.O. :, 2002), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
- Medicare endorsed prescription drug discount card (U.S. G.P.O. :, 2002), by United States. Congress. House. Committee on Small Business (page images at HathiTrust)
- Medicare reform (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)
- Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007. (U.S. G.P.O. :, 2013), by Science United States. Congress. Senate. Committee on Commerce (page images at HathiTrust)
- Options for safe and effective prescription drug importation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, second session, March 11, 2004. (U.S. G.P.O. :, 2012), by United States Senate Committee on Commerce, Science, and Transportation (page images at HathiTrust)
- Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009. (U.S. G.P.O. :, 2012), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
- Strategies used by adults to reduce their prescription drug costs (Hyattsville, MD : U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2013., 2010), by Robin A. Cohen, Renee M. Gindi, Whitney K. Kirzinger, and National Center for Health Statistics (U.S.) (page images at HathiTrust)
- Strategies used by adults to reduce their prescription drug costs : United States, 2013 (Hyattsville, MD : U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2015., 2015), by Robin A. Cohen, Maria A. Villarroel, and National Center for Health Statistics (U.S.) (page images at HathiTrust)
- Prescription drug advertising to consumers : staff report (U.S. G.P.O., 1984), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
- Evaluation of the maximum allowable cost (MAC) for drugs program : phase I report : final design report and report of pilot study analysis (DHHS, Health Care Financing Administration, Office of Research, Demonstrations, and Statistics, 1980), by A. James Lee, Ralph Hardy, Dennis Hefner, Abt Associates, and Demonstrations United States. Health Care Financing Administration. Office of Research (page images at HathiTrust)
- Reducing drug costs to Medicare (U.S. G.P.O. :, 2011), by United States Senate Special Committee on Aging (page images at HathiTrust)
- FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (U.S. G.P.O. :, 2010), by Postal Service United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Federal Workforce (page images at HathiTrust)
- Implementation of the Medicare drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session,May 3 and May 4, 2006 (U.S. G.P.O. :, 2011), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)
- Medicaid prescription drugs : examining options for payment reform : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, June 22, 2005. (U.S. G.P.O. :, 2005), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
- Public attitudes toward prescription costs and the drug industry; a report by the National Opinion Research Center of the University of Chicago, based on preliminary tabulations from the summer 1955 survey. (Health Information Foundation, 1960), by National Opinion Research Center (page images at HathiTrust; US access only)
- Expanding access to federal prices could cause other price changes (Washington, D.C. (P.O. Box 37050, Washington, D.C. 20013) : The Office, [2000], 2000), by United States General Accounting Office (page images at HathiTrust)
More items available under broader and related terms at left. |